Search Results

Finally, a Drug for Alzheimer’s?

• Authors : Langreth, Robert (AUTHOR); Tozzi, John (AUTHOR); Griffin, Riley (AUTHOR)

Subjects: *DRUG prices; ALZHEIMER'S disease treatment; CLINICAL drug trialsBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB

• Source: Bloomberg Businessweek. 5/17/2021, Issue 4699, p16-19. 4p. 2 Color Photographs.

Record details

After 190 Tries, Are We Any Closer to a Cure for Alzheimer's?

• Authors : Langreth, Robert (AUTHOR); Koons, Cynthia (AUTHOR); Chen, Caroline (AUTHOR)

Subjects: *PHARMACEUTICAL industry; ALZHEIMER'S disease treatment; AMYLOID

• Source: Bloomberg Businessweek. 6/27/2016, Issue 4480, p38-39. 2p. 1 Color Photograph, 1 Chart.

Record details

HOT SEAT: BIOGEN’S ADUHELM DRUG.

• Authors : Peebles, Angelica (AUTHOR)

Subjects: ADUCANUMAB; ALZHEIMER'S disease treatment; DRUG efficacyBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB

• Source: Bloomberg Businessweek. 1/17/2022, Issue 4727, p23-23. 2/3p. 1 Color Photograph.

Record details

The Killer Cost of Alzheimer's.

• Authors : Coy, Peter

Subjects: *ECONOMICS; CARE of Alzheimer's patients; ALZHEIMER'S disease treatmentUNITED States

• Source: Bloomberg Businessweek. 4/29/2013, Issue 4327, p6-7. 2p. 1 Graph.

Record details

Taking Aim at Alzheimer's.

• Authors : Murphy, Kate

Subjects: ALZHEIMER'S disease diagnosis; ALZHEIMER'S disease treatment

• Source: BusinessWeek. 2/17/97, Issue 3514, p103-106. 2p. 1 Color Photograph.

Record details

Alzheimer’s Drug Furor Shows Two Failures in The U.S. Health System.

Subjects: ALZHEIMER'S disease treatment; DRUG approvalUNITED States. Food & Drug Administration

• Source: Bloomberg Businessweek. 6/21/2021, Issue 4703, p10-10. 3/4p.

Record details

IN BRIEF.

• Authors : Kammel, Benedikt (AUTHOR)

Subjects: *COVID-19 pandemic; ALZHEIMER'S disease treatment; PRESIDENTIAL electionsBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIBCASTILLO, Pedro

• Source: Bloomberg Businessweek. 6/14/2021, Issue 4702, p6-6. 1p. 3 Color Photographs.

Record details

Biogen's New Alzheimer's Drug Faces Hurdles Reaching Patients, Even if It's Approved.

• Authors : Tozzi, John (AUTHOR)

Subjects: ALZHEIMER'S disease treatment; ALZHEIMER'S patients; DRUG approvalBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB

• Source: Bloomberg.com. 5/24/2021, pN.PAG-N.PAG. 1p.

Record details

It's Make or Break Time for Biogen's Alzheimer's Drug.

• Authors : Langreth, Robert (AUTHOR)

Subjects: ALZHEIMER'S disease treatment; CLINICAL drug trials; PHARMACEUTICAL researchBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB

• Source: Bloomberg.com. 12/4/2019, pN.PAG-N.PAG. 1p.

Record details

A $28 Billion Shopping List for Biogen.

• Authors : Nisen, Max

Subjects: *PHARMACEUTICAL industry mergers; ALZHEIMER'S disease treatmentBIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIOGEN Inc. (2003- ) BIIB; SAGE Therapeutics Inc. ; SAREPTA Therapeutics Inc.

• Source: Bloomberg Opinion. 3/22/2019, p9-9. 1p.

Record details